Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Blood and Lymphatic Diseases clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Blood and Lymphatic Diseases: 1 US clinical trial tracked, none currently recruiting.

Blood and Lymphatic Diseases is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Sangamo Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition blood-and-lymphatic-diseases

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Blood and Lymphatic Dise (th…0%
Open-enrollment share among volume-matched conditions near Blood and Lymphatic Diseases

Blood and Lymphatic Diseases has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blood and Lymphatic Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blood and Lymphatic Diseases is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Blood and Lymphatic Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

ST-400 Drug
1 trials
BIVV003 Drug
1 trials

US sites by state

Facility locations filed on Blood and Lymphatic Diseases trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Michigan 1 trials
Massachusetts 1 trials
Georgia 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blood and Lymphatic Diseases page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Blood and Lymphatic Diseases trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Sangamo Therapeutics sponsors the most Blood and Lymphatic Diseases trials on record, review their full trial history before evaluating a specific study. See Sangamo Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood and Lymphatic Diseases condition card totals 1 registered trials; most-linked intervention ST-400; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.